Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Clinical trial NCT03968406 · RECRUITING

Trial details

NCT number: NCT03968406
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Female Reproductive System Neoplasm Recurrent Cervical Carcinoma Recurrent Endometrial Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Vaginal Carcinoma Stage IV Cervical Cancer AJCC v8 Stage IV Fallopian Tube Cancer AJCC v8 Stage IV Ovarian Cancer AJCC v8 Stage IV Primary Peritoneal Cancer AJCC v8 Stage IV Uterine Corpus Cancer AJCC v8

Start date: 2019-09-26
Primary completion: 2027-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.